Patent · US Active

Stabilized liquid fosaprepitant formulations

US9913853B2 · kind B2 · utility

5Cited by
1References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 3, 2016
Grant dateMar 13, 2018
Priority date
Expiry dateNov 3, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to stable pharmaceutical compositions of fosaprepitant or a salt thereof in the form of ready-to-use or ready-to-dilute compositions suitable for parenteral administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.